Novartis boosts outlook, announces $2.1B Endocyte deal
The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.
via FOX BUSINESS NEWS Markets
https://ift.tt/2yl71n6
Trending FOX BUSINESS News: Novartis boosts outlook, announces $2.1B Endocyte deal
Novartis boosts outlook, announces $2.1B Endocyte deal
The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.
via FOX BUSINESS NEWS Markets
https://ift.tt/2yl71n6
